CONFIDENTIAL
Saint Louis University | Intellectual Property Disclosure Form | version 2017v02 | Page 3 of 12
II. Intellectual Property Information
Intellectual Property Title:
Property Type
(Select all
Indicate Current Level of Development
TRL-1: The principles that underlie the technology have been identified.
TRL-2: The application being considered has been outlined and analysis to
support the concept has been provided.
TRL-3: Laboratory tests have been performed to measure parameters of
interest and compare to analytical predictions for biological functions
critical subsystems.
TRL-4: System concepts have been considered and test results are available
from in vitro experiment(s), laboratory-scale breadboard(s), or
prototype(s).
TRL-5: Results available from in vivo experiment(s) or laboratory-tested
breadboard system(s) or prototype(s) that have been integrated with other
supporting elements in a simulated operational environment.
(Explain below):
TRL-6: Results available from phase 1 clinical trial or laboratory testing of a
prototype system that is near the desired configuration in terms of
performance, weight, and volume.
TRL-7: Phase 2 clinical trial plan is prepared or results are available from
testing a prototype system in an operational environment.
TRL-8: Results available from phase 2 clinical trial or testing the system in
its final configuration under the expected range of environmental
conditions in which it will be expected to operate.
TRL-9: The technology has begun phase 3 clinical trial or actually been
applied in its final form and under mission conditions, such as those
encountered in operational test and evaluation (OT&E).
Other (Please explain below):